Abstract | OBJECTIVE: To test the hypothesis that implementation of a marked reduction in intravenous fat will result in reversal of parenteral nutrition-associated liver disease (PNALD) in infants. STUDY DESIGN: RESULTS:
Intravenous fat emulsion reduction resulted in a significant decline in total bilirubin levels compared with controls. Comparison of growth in the 2 groups was similar. Mild essential fatty acid deficiency was detected in 8 of 31 infants and was reversed with additional days of lipid infusion. No significant adverse events were noted. CONCLUSIONS: An association between intravenous lipid emulsion administration and the development of PNALD seems probable. Use of intravenous fat emulsion reduction is a potential approach to reverse PNALD in young infants. Frequent monitoring of essential fatty acid deficiency is needed with the use of this regimen.
|
Authors | Mary Petrea Cober, Ghassan Killu, Allison Brattain, Kathleen B Welch, Shaun M Kunisaki, Daniel H Teitelbaum |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 160
Issue 3
Pg. 421-7
(Mar 2012)
ISSN: 1097-6833 [Electronic] United States |
PMID | 21982303
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Mosby, Inc. All rights reserved. |
Chemical References |
- Fat Emulsions, Intravenous
- Fatty Acids, Essential
- Bilirubin
|
Topics |
- Bilirubin
(blood)
- Cholestasis
(blood, etiology, therapy)
- Fat Emulsions, Intravenous
(administration & dosage, adverse effects)
- Fatty Acids, Essential
(deficiency)
- Female
- Humans
- Infant, Newborn
- Liver Diseases
(blood, etiology, therapy)
- Male
- Parenteral Nutrition
(adverse effects)
|